At the Cusp of Breakthroughs,” “Game Changer,” “At Last, an Answer.” As you can tell from our headlines, so much is happening here in the Division of Rheumatology. If we […]
LEAP Winter 2024: At the Cusp of Breakthroughs
Promotions
LEAP Rounds – Winter 2023
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of many cancers, enabling long-term remission and potentially curative responses. But there’s a downside: these drugs also can result in inflammatory syndromes […]
LEAP Rounds – Fall 2023
Never underestimate the body’s ability to compensate. We have seen this in our patients with inclusion body myositis (IBM), thanks in part to musculoskeletal ultrasound, as part of a recent […]
LEAP – Winter 2023: Big Data, Individualized Care
In Rheumatology, we have more bits of information about our patients with chronic diseases than we can manage, without help. Just one visit, for example, generates results of tests and […]
LEAP Rounds – Holiday 2022
Our Patient-Reported Outcomes Measurement Information System-Physical Function (PROMIS PF) Minimal Disease Activity (MDA), a tool developed at Johns Hopkins and validated within our PsA cohort, allows for exquisite description of […]
LEAP Rounds – Fall 2022
In 2015, Johns Hopkins scientists proved that scleroderma is often a casualty of war: it is the unfortunate consequence of the body’s battle to fight off cancer. We have since […]
